Clinical Trials List
2020-12-15 - 2029-12-31
Phase III
Recruiting10
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- Shih Hsin Tu Division of Hematology & Oncology
- Wen-Ke Wang Division of General Surgery
- Kuan-Der Lee Division of Hematology & Oncology
- Huey-En Tzeng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Jung Chen Division of General Surgery
- Yao-Chung Wu Division of General Surgery
- Liang-Chih Liu Division of General Surgery
- 黃至豪 Division of General Surgery
- Chen-Teng Wu Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsu-Yi Chao Division of Hematology & Oncology
- I-Chan Lin Division of Ophthalmology
- Yao-Yu Hsieh Division of Hematology & Oncology
- KUAN-RAU CHIOU Division of Cardiovascular Diseases
- HUI-WEN LIU Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- Wei-Hong Cheng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林柏翰
- Wei-Wu Chen Division of Hematology & Oncology
- WEI-LI MA Division of Hematology & Oncology
- 林季宏
- 陳怡君
- 羅喬 Division of Hematology & Oncology
- MING-YANG WANG
- 魏以宣 Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳佳哲
- 陳怡豪 Division of Ophthalmology
- 劉文浩 Division of Cardiovascular Diseases
- Shau-Hsuan Li
- 陳彥仰 Division of Hematology & Oncology
- Tai-Jan Chiu
- 黃詩喻 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 賴香蘭 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 沈士哲
- Wen-Ling Kuo
- Pei-Wei Huang
- Wen-Chi Shen Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- Chi-Chang Yu
- 周旭桓
- Mengting Peng Division of Hematology & Oncology
- 何蕙余
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kuan-Der Lee Division of Hematology & Oncology
- I-Chen Tsai
- ZHENG-WEI ZHOU
- Huey-En Tzeng Division of Hematology & Oncology
- 王國鐘 Division of General Surgery
- 林慈恩 Division of General Surgery
- 劉明承
- HSIN-CHEN LIN Division of Hematology & Oncology
- 楊陽生
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊舜如 Division of Hematology & Oncology
- Chun-Hui Lee
- Jui-Hung Tsai
- Yao-Lung Kuo
- Zhu-Jun Loh
- Kuo-Ting Lee
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
65 participants
-
Global
1680 participants
